mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |